of the (-cyclic AMP/+cyclic AMP) protein kinase activity ratios in freshly prepared tissue extracts (40,000 x g supernates) from bovine renal medullary slices. The activation of protein kinase was specific for vasopressin since parathyroid hormone, histamine, angiotensin II, or the inactive analog of vasopressin did not activate protein kinase. There was a direct correlation between the extent of protein kinase activation and the elevation in tissue levels of cyclic AMP elicited by increasing doses of vasopressin or with an increase in incubation time. The elevation of tissue cyclic AMP level and maximum activation of protein kinase reached maximum level at a vasopressin concentration of about 2 x 10vg M. Incubation of slices with vasopressin caused a dose-dependent decrease in the cyclic AMP-dependent protein kinase activity in the 40,000 x g supernate of homogenate from the renal medullary slices. This effect of vasopressin was specific for protein kinase since activity of lactate dehydrogenase or a specific [3H]colchicine-binding activity was not affected, and the decrease in the protein kinase was not due to the accumulation of a heat-stable protein kinase inhibitor.
There was an increase in protein kinase activity extracted from 40,000 x g pellets of homogenate prepared from slices exposed to vasopressin. Results thus provide evidence that cyclic AMP-mediated protein kinase activation in the intact cells is an integral part of cellular response of the mammalian renal medulla to vasopressin.
ADH; kidney, in situ activation; cyclic AMP
IT IS GENERALLY ACKNOWLEDGED thatvasopressin (VP) stimulates cyclic AMP formation and its accumulation in target cells, but the mechanism by which cyclic AMP elicits the increase in luminal plasma membrane water permeability (11, 13) -the ultimate functional response to the hormone -has not been elucidated (11, 13, 14) . It has been proposed that cyclic AMP may regulate the water permeability of collecting ducts by influencing the phosphorylation of specific membrane proteins (10). This hypothesis is indirectly supported by the finding of a cyclic AMP-dependent protein kinase in the mammalian renal medulla (3, 10, 20, 22) , by the fact that proteins of the plasma membrane fraction from renal medulla can serve as a substrate for this enzyme (lo), and also by the fact that phosphorylated plasma membrane proteins can be dephosphorylated by a protein phosphatase which is also present in this tissue (3, 10) . Some investigators have proposed that cyclic AMP-dependent protein kinase is localized directly in the luminal plasma membrane of the renal medulla (22). Studies on the subcellular distribution of cyclic AMP-dependent protein kinase and protein phosphatase in the renal medulla indicated that most of the cyclic AMP-dependent protein kinase and protein phosphatase activities are found in the fraction of soluble proteins (cytosol) (3). All the above-mentioned studies were performed on cellfree preparations from homogenized renal medullary tissue and indicate only indirectly that the proposed cyclic AMP-dependent phosphorylating mechanism can possibly occur in intact, VP-sensitive cells.
In the present study we examined whether VP, through mediation of cyclic AMP, activates protein kinase in situ, i.e., in intact, unbroken renal medullary cells. The extent of cyclic AMP-dependent protein kinase activation by VP in intact tissue was assessed by the ratio of protein kinase activities measured without or with addition of a maximal stimulatory dose of cyclic AMP in freshly prepared extracts from control tissues and from tissues after exposure to the hormone, an approach designed (7, 23) and previously used in studies of some other hormone-sensitive tissues (12, 15, 23, 26, 28) .
MATERIALS AND METHODS
Tissue slices of 0.5 mm thickness from bovine renal medulla were prepared using a Stadie-Riggs tissue slicer and were thoroughly washed at least 5 times in a large volume of ice-cold medium of the following composition, in millimoles per liter: NaCl, 140; KCl, 5; MgS04, 1.2; CaC1,, 0.8; glucose, 10; acetic acid, 10; sodium phosphate, 2; and Tris, 20 (pH 7.4). Slices were randomly distributed into 25.ml flasks (400 mg tissue per 4 ml of medium) and kept at 0°C until incubation.
Incubation. The slices were first preincubated for 20 min at 30°C in the medium described above. After preincubation, slices were transferred to 4 ml of the same medium which contained also 0.2 mM 1-methyl-3-isobutylxanthine (MIX). Slices were then incubated at 30°C without or with addition of VP or other agents to be tested, added at zero time. Unless otherwise stated, the incubation time was 20 min. At the end of the incubation period, slices were removed from the incubation
medium, quickly minced with scissors, and homogenized immediately in 2.8 ml of ice-cold medium of the following composition: 0.25 M sucrose, 5 mM potassium phosphate, 2 mM EDTA (ethylenediaminetetraacetic acid), and 0.5 mM MIX (pH 7.0)) using a Teflon-pestle glass homogenizer.
Also, all the following steps were carried out at 0-4°C. The homogenate was filtered through nylon cloth (mesh size, 390; Nytex Co.), and 0.5 ml of homogenate was immediately mixed with an equal volume of ice-cold 10% trichloroacetic acid (TCA) and set aside for determination of cyclic AMP content. The homogenate was then centrifuged at 40,000 x g for 10 min and the supernate was immediately assayed for protein kinase activity.
Remaining supernate was either frozen immediately in Dry Ice, or in some experiments, an aliquot of the supernate was mixed with a buffer of the following composition: 3 mM guanosine 5'-triphosphate (GTP), 30 mM MgC&,, and 30 mM potassium phosphate (pH 6.8) in a ratio of 2 volumes of supernate to 1 volume of buffer. This aliquot of extract was also quickly frozen in Dry Ice and used later for determination of the [3H]colchicine-binding activity. Frozen supernates were stored at -80°C until assayed for [3H]colchicine-binding activity or lactate dehydrogenase activity or used for preparation of heat-stable protein kinase inhibitor extracts.
Protein kinase assay. The protein kinase activity in the 40,000 x g supernate was assayed in an incubation mixture of 200 ~1 total volume containing the following ingredients in final concentration: 10 mM MgCIZ, 2 mM theophylline, 0.3 mM EGTA (ethylenebis-[oxyethylenenitriloltetraacetic acid), 10 mM NaF, 2.5 x lo-" M [Y-~~P]ATP (2-3 million cpm per tube), 100 pg of mixed calf-thymus histones (type II-A; Sigma Chemical Co., St. Louis), and 50 mM sodium P-glycerophosphate (pH 6.5). The incubation was started by addition of 10 ~1 of the enzyme extract containing 8-15 pg of protein per tube, and the incubation was carried out for 5 min at 30°C. The incubation was terminated by addition of 1 ml of 10% TCA. The 32P incorporated into the protein was measured using the same procedure as in our previous studies (8, 9) . The final TCA protein precipitate was collected on glass-fiber filters (GF/C, Whatman, Inc.), and 32P was determined by liquid scintillation counting. In the above described extract, the protein kinase activity was linear with enzyme protein at least up to 25 pg of protein per tube and was directly proportional to time for at least 8 min. The specific protein kinase activity is expressed in picomoles of 32P incorporated into protein per 5 min per milligram protein of enzyme extract. Several protein substrates were tested and, as shown on Table 1 , casein was a rather poor substrate for renal medullary protein kinase and was only slightly stimulated by cyclic AMP. Mixed calf-thymus histones (type II-A; Sigma) and fraction F2b were both effective substrates for the phosphorylation by the protein kinase which was stimulated by cyclic AMP 5x and 10~) respectively. Cyclic AMP-dependent protein kinase measured with these histones as substrates was completely inhibited by heat-stable protein kinase inhibition (Table 1) prepared from rabbit skeletal muscle (1). Type II- A mixed calf-thymus histones were then routinely used for all subsequent assays. Using this substrate, the maximal stimulation by cyclic AMP was at concentrations between low6 and 10m5 M. In preliminary experiments it was determined that autoincorporation of 32P into enzyme preparations was less than lo%, and therefore was not routinely subtracted (6). All protein kinase assays were run in triplicates. Based on the general molecular mechanism of protein kinase activation by cyclic AMP (17), it was shown that the (-cyclic AMP/ +cyclic AMP) protein kinase activity ratio can be used for at least a semiquantitative measurement of activation of this enzyme in intact cells (7, 23) in a variety of tissues (12, 15, 23, 24, 28) . Protein kinase activity measured after addition of a maximum stimulatory dose of cyclic AMP is referred to as the total protein kinase activity. The activity calculated by subtracting the activity measured without addition of cyclic AMP from total protein kinase activity is referred to as the net cyclic AMP-dependent protein kinase activity. The basal (-cyclic AMP/ + cyclic AMP) protein kinase activity ratio in control incubations (without addition of hormones) varied from one kidney preparation to another, a feature observed also in another study (15) . Therefore, effects of VP and other agents were always tested in the same experiment using the same batch of tissue slices and biochemicals, and the results were evaluated by paired comparison with the controls. In preliminary experiments, it was determined that the (-cyclic AMP/+cyclic AMP) protein kinase activity ratio in fresh extracts kept at 0-2°C (either control or after exposure to VP) did not change for at least 60 min after homogenization.
CycZic AMP binding. This was determined by the method described by Traugh, Ashby, and Walsh (26) with minor modifications. The tested extract (40-70 pg/ tube) was incubated at 30°C for 15 min in a mixture (total volume, 100 ~1) of the following composition: 15 nM cyclic [3H]AMP (34,000 cpm per tube), 1 mM MgC12, 0.1 mg/ml of bovine serum albumin, and 5 mM sodium acetate (pH 4.5). At the end of the incubation period, 200 ~1 of charcoal suspension (25) in a buffer was added, which contained 40 mM MgCl, and 10 mM Tris-HCl (pH 8.0); the suspension was thoroughly mixed and immediately centrifuged in the cold at 10,000 x g for 2.5 min. Protein-bound cyclic AMP in the supernate was determined by liquid scintillation counting. Using charcoal for separation gave results identical to those obtained by isolation of protein-bound cyclic AMP by Millipore filtration (26) . Under the present conditions, cyclic AMP binding was linear at least up to 100 rug protein per tube.
Cyclic AMP determination. TCA-precipitated proteins were removed by centrifugation at 10,000 x g for 10 min and the TCA was removed by extraction with water-saturated ethyl ether. The TCA-free extracts were then purified on Dowex l-x8 columns using elution with 2 N formic acid as described by Murad et al. (20) . The recovery, followed by inclusion of cyclic [3H]AMP into the original extract, was about 7080%. Cyclic AMP in the purified extract was determined using a modified competitive protein binding assay (25) and expressed in picomoles per milligram of the tissue protein.
Lactate dehydrogenase. This was assayed using the same method employed in our previous study (2). The assay of [3H]colchicine binding was essentially the same as utilized in our previous study (9 Heat-stable protein kinase inhibitor. The 40,000 x g supernate from slices incubated either with or without VP was heated for 10 min in a boiling water bath and then dialyzed against buffer containing 0.5 mM p-glycerophosphate and 20 PM EDTA for 24 h (1). The dialyzed extracts were lyophilized, dissolved in distilled water, and kept frozen at -20°C (1). The inhibitory activity was tested on protein kinase stimulated by 5 x lo+ M cyclic AMP (1). The inhibitor from rabbit skeletal muscle was prepared in a similar way (1).
The protein determination in all extracts was performed by the method of Lowry et al (18) were supplied by Aldrich Chemical Co., Milwaukee. Other chemicals and biochemicals, all of highest purity grade, were from standard suppliers.
RESULTS
In a system originally developed for adipose tissue (7, 23), homogenization of tissue in a medium containing 0.5 M NaCl was of advantage since it apparently prevented reassociation of catalytic and regulatory subunits of protein kinase after homogenization and dilution. However, use of high NaCl concentration can inhibit the protein kinase or apparently cause dissociation of the enzyme in some other tissues (5, 15, 23) . For the present study, use of homogenization medium containing 0.5 M NaCl was compared with a medium containing 0.25 M sucrose as described in METHODS.
Results summarized in Table 2 show that by using a medium of either composition, a significant increase was detected in the ( -cyclic AMP/ + cyclic AMP) protein kinase activity ratio after incubation of tissue slices with AVP. Extracts prepared in our standard sucrose medium and those prepared in medium containing 0.5 NaCl differed in that the control (-cyclic AMP/ +cyclic AMP) protein kinase activity ratio was much higher in 0.5 NaCl medium and that the increase in the ratio after AVP was due solely to the increase in the activity assayed without addition of cyclic AMP. Total protein kinase activity (assayed in the presence of added maximum concentration of cyclic AMP) from slices incubated in the presence of AVP did not change. Total protein kinase activity for control slices is lower in 0.5 M NaCl extract, possibly due to the inhibitory effect of high salt concentration on protein kinase as observed also in other studies (7, 10). On the other hand, in a medium containing 0.25 M sucrose the increase in (-cyclic AMP/ +cyclic AMP) protein kinase ratio was due to the simultaneous increase in activity without cyclic AMP addition and a decrease in total protein kinase activity ( Table 2 ). The relative increase in the (-cyclic AMP/+cyclic AMP) protein kinase activity ratio with 2.5 x 10v7 M AVP, a concentration of hormone which stimulates maximally bovine renal medullary adenylate cyclase (3), was not markedly different with use of 0.5 NaCl (about +34.4%) from the increase with standard sucrose medium (about +36.7%). Therefore, in all other experiments, a medium containing 0.25 M sucrose (described in METHODS) was used.
When tissue slices were incubated for different time periods, in the absence of AVP, the protein kinase (-CAMP/ +cAMP) activity ratio as well as cyclic AMP levels remained constant up to 30 min (Fig. 1) . A slight, insignificant increase in both parameters in the first few minutes of incubation is likely due to transfer of slices to medium containing 0.2 mM MIX. On the other hand, in the presence of added AVP there was marked increase in both cyclic AMP and protein kinase (-cAMP/+cAMP) activity ratios within the first 5 min, and both parameters leveled off between 5 and 30 min. Changes with time in the kinase activation and cyclic AMP levels went in parallel, and a significant correlation between the two parameters was found (Fig. 1) . Increasing doses of AVP (lo-l0 to 10m6 M) elicited a gradual elevation of tissue cyclic AMP concentration and a parallel increase in the (-cyclic AM.P/ +cyclic AMP) protein kinase activity ratio (Fig. 2) . There was also a progressive increase in protein kinase activity measured without addition of exogenous cyclic AMP and a decrease in the total and net cyclic AMP-dependent protein kinase activities (Fig. 2) . All these changes in protein kinase parameters were significantly correlated with AVP-elicited increases in tissue cyclic AMP (Figs. 2 and 3) . The maximum increases both in cyclic AMP levels and maximum changes in protein kinase parameters reached a plateau at an AVP concentration of about 2 x 10mg M in the present system (Fig. 2) . Protein kinase activation in renal medullary slices was specific for AVP. (Des-Glyg-NH,)-oxytocin, an inactive analog of VP1 and some other hormones which are known either to stimulate adenylate cyclase in other target tissues (PTH, histamine) or elicit biological effects probably without mediation of cyclic AMP (angiotensin II),2 had no significant effect on protein kinase activation (Table 3) . To examine whether the decrease in total protein kinase activity is a specific feature of this cytosolic enzyme (3), the effects of AVP on cyclic AMP levels, on protein kinase activity, and on the activity of two other components of renal medullary cytosol were measured simultaneously.
Results summarized in Table 4 show that while AVP markedly increased cyclic AMP levels and decreased total protein kinase activity, it had no effect on the activity of lactate dehydrogenase or on the [3H]colchicine-binding activity in the same extracts. The specificity of AVP-induced changes is further stressed by the observation that (des-Glyg-NH,)-oxytotin had no effect on the measured parameters (Table 4) . We explored whether AVP-induced decreases in total protein kinase and net cyclic AMP-dependent protein kinase activities were possibly due to accumulation of a heat-stable protein kinase inhibitor (1, 27) in tissue slices incubated with AVP. Tissue slices were incubated without or with AVP and protein kinase activity and cyclic AMP levels were determined.
Aliquots of tissue extracts from these incubations were processed as described in METHODS to obtain preparations which were subsequently tested for the presence of the heat-stable protein kinase inhibitor. Samples were diluted in such a way that preparations from paired control and AVPtreated tissues had equal protein concentrations.
No inhibition of protein kinase activity was detected after addition of extracts either from control or AVP-treated tissue preparations.
On the other hand, protein kinase inhibitor prepared in a similar way from rabbit skeletal muscle, a tissue known to contain a high quantity of this inhibitor (27), completely inhibited cyclic AMPdependent protein kinase activity in the present system (Table 1) . (---0---0--) , ( -cyclic AMP/ + cyclic AMP) protein kinase activity ratio. Upper panel: ( -l -0 -), protein kinase activity without addition of cyclic AMP; ( -0 -0 -), total protein kinase activity;
(---W--W-->, net cyclic AMP-dependent protein kinase activity.
A close positive correlation was found between tissue cyclic AMP levels and (-cyclic AMP/ + cyclic AMP) protein kinase activity ratio (see Fig. 3 ), as well as between cyclic AMP levels and protein kinase activity measured without added cyclic AMP (r = 0.5145; P < 0.01). There was a significant negative correlation between cyclic AMP levels and total protein kinase activity (r = 0.3968; P < 0.05), and between cyclic AMP levels and net cyclic AMP-dependent protein kinase activity (r = 0.5392; P < 0.01).
Further, we tested whether the decrease in total protein kinase activity is due to attachment (or "translocation" (16)) of protein kinase from the supernate to the particulate fraction sedimenting at 40,000 x g. Slices were incubated with or without AVP, homogenized, and the homogenate was centrifuged at 40,000 x g for 10 min as described in METHODS. In the supernate, protein kinase activity as well as cyclic AMP binding capacity was determined. The 40,000 x g pellet was resuspended in the homogenization medium and centrifuged again at 40,000 x g for 10 min to wash out remaining supernate.
This washed pellet was then suspended in a medium containing 300 mM NaCl and 5 mM sodium phosphate (pH 7.0). The suspended pellet was extracted by stirring in an ice-cold (0-2°C) bath for 60 min. The suspension was then centrifuged at 40,000 x g for 10 min, and the supernate was appropriately diluted and assayed for 
+8.4+4.3 NS Values are means 2 SE; n denotes number of paired observations. Changes in the protein kinase activity ratio (-cyclic AMP/+cyclic AMP) after addition of tested agents are expressed as percent of control incubations; (-cyclic AMP/+cyclic AMP) ratio of controls was taken as 100%.
* For significance of changes; paired-t test; NS denotes P > 0.05.
protein kinase activity without cyclic AMP and with 5 x 10B6 M cyclic AMP. Moreover, protein kinase both in the supernate and in the extract from pellets was also assayed with cyclic AMP and heat-stable protein kinase inhibitors prepared from rabbit skeletal muscle (see METHODS, Table 1 ) at the dose of inhibitor which completely suppresses the activity of cyclic AMP-dependent protein kinase (26). The results summarized in Table 5 show that the increases in the (-cyclic AMP/ +cyclic AMP) protein kinase activity ratio and in the activity of protein kinase measured without cyclic AMP, as well as the decrease in total protein kinase activity, were accompanied by marked decrease in cyclic AMP binding capacity in the same supernate (Table 5 , part A). Protein kinase activities in extracts from pellets obtained from slices exposed to AVP were significantly higher than in extracts from controls ( kinase activity ratio after incubation with AVP. The activity of protein kinase assayed in the presence of added cyclic AMP plus protein kinase inhibitor, which represents protein kinase not regulated by cyclic AMP (26), was not changed after incubation with AVP either in the supernate or in the extract from pellets (Table 5) .
DISCUSSION
In mammalian renal medulla, cyclic AMP-dependent protein kinase is predominantly a cytosolic enzyme (3) and studies on rabbit renal medullary protein kinase indicate the presence of at least two cyclic AMP-dependent subfractions of the enzyme (21). In order to examine whether VP activates protein kinase in situ we used measurement of the (-cyclic AMP/ +cyclic AMP) protein kinase activity ratio (7, 23), a method designed originally for adipose tissue. In spite of differences in stoichiometry (5, 17), the basic mechanism of protein kinase activation by cyclic AMP appears to be similar for different organs and animal species (7, 17; 23) , and the method using measurement of (-cyclic AMP/ +cyclic AMP) protein kinase activity ratio (22) appears to be generally applicable (7, 12, 15, 20, 24, 28) .
In the present study, we observed that incubation of renal medullary slices with AVP leads to an increase in (-cyclic AMP/ +cyclic AMP) protein kinase activity ratio, and that this increase is hormone specific (Table 3) and is dependent on the dose of AVP. Furthermore, a close quantitative correlation between the protein kinase activation and AVP-elicited increase in tissue level of cyclic AMP was found both in the initial time phases of incubation ( Fig. 1) and after 20 min with various doses of AVP (Figs. 2 and 3) .
The AVP-induced increase in ( -cyclic AMP/ + cyclic AMP) protein kinase activity ratio is accompanied by an increase in the tissue level of cyclic AMP (Table 4) and by a decrease in cyclic[3H]AMP binding capacity in the 40,000 x g supernate (Table 5 , line a); the latter finding suggests that in AVP-treated slices the cyclic AMP binding sites on the regulatory subunits of protein kinase (16) are occupied by endogenous cyclic AMP (26).
The (-cyclic AMP/ +cyclic AMP) protein kinase activity ratio elevated by the saturating doses of AVP never approached a value of 1.0, a ratio which would be theoretically expected (7, 17, 23) if the cyclic AMPdependent protein kinase is fully dissociated to catalytic and regulatory subunits (17). At least two alternative explanations for this observation could be entertained. First, renal medulla contains, in addition to the VPresponsive cells of collecting ducts, a variety of other cell types possibly responsive to agents other than AVP and containing protein kinase. Stimulation of cell-free preparations from mammalian renal medulla by agents such as glucagon, isoproterenol (N), or prostaglandins (4) has been observed. All these agents apparently stimulate adenylate cyclases different from that associated with VP receptor. Thus, it could be expected that AVP increases the cyclic AMP level and activates protein kinase only in the AVP-sensitive cell population, while cyclic AMP and protein kinases from other cell types lated by cyclic AMP and was strongly inhibited by a contained in renal medulla remain unaffected?
heat-stable, protein kinase inhibitor. These features It is also possible that factors such as a high rate of cyclic AMP breakdown, efflux of cyclic AMP from cells, or some as yet unknown negative feedback regulatory mechanism at the cellular level may limit the maximal increase in cyclic AMP tissue levels by VP and prevent maximal activation of protein kinase. That these factors may indeed play a role is suggested by the finding that incubation of slices with 8-Cp-chlorophenylthiol-cyclic AMP, a potent cyclic AMP analog which is resistant to cyclic AMP breakdown, activates protein kinase in renal medullary slices to a much greater degree than maximal doses of AVP (2). sugges pellets t that most of the protein kinase in extracts from .s free cata lytic s ubunits of the enzyme (26) . The 1 observation that AVP elicits changes in the activity a nd distribution of only the protein kinase suppressible bY heat-stable protein kinase inhibitor demonstrates that AVP acts only on the cyclic AMP-dependent protein kinase in the renal medulla (26). A similar translocation was also observed in other hormone-responsive systems, but it is unresolved at the present time whether this finding reflects an intracellular event (16). In conclusion, the present results provide the first evidence that cyclic AMP-dependent protein kinase is The relative changes in tissue cyclic AMP levels in response to AVP (in terms of percent increase above control) are larger than the relative changes in protein kinase activation.
This suggests that only a certain portion of cyclic AMP generated in response to VP is available for and operative in the protein kinase activation. Nevertheless, the very close correlation between tissue levels of cyclic AMP and the extent of protein kinase activation, both in time and in relation to the dose of VP, as well as the specificity of VP effect, suggest that protein kinase activation is an integral step in the cellular action of VP in the renal medulla. specifically and in a dose-dependent way activated by VP in intact cells and that this activation is correlated with VP-induced changes in tissue cyclic AMP level. The mechanism by which activated soluble protein kinase elicits the ultimate functional response to VP remains to be elucidated. Although the proteins of plasma membranes from the renal medulla (10, 22) or cytosolic
